Conjugate vaccines;Les vaccins conjugués

Revue Medicale de Bruxelles

Volumn 23, Issue 4, 2002, Pages

  Swennen, B ^a   Sternon, J ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Conjugate vaccine; Haemophilus influenzae de type b; Meningococcal serogroup C disease; Pneumococcal disease

Indexed keywords

INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; INFLUENZA; MENINGOCOCCOSIS; SEROTYPE; STREPTOCOCCUS INFECTION; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; IMMUNOGLOBULIN G; INFANT; MENINGOCOCCAL INFECTIONS; PNEUMOCOCCAL INFECTIONS; VACCINES, COMBINED;

EID: 0036744893     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (41)

1. Gordon A : Vaccines and vaccination. N Engl J Med 2001 ; 345 : 1042-53
2. Pittman M : Variation and type-specific in the bacterial species H. influenzae. J Exp Med 1931 ; 53 : 471-95
3. Fothergill LD, Wright J : Influenzal meningitis : The relation of age incidence to the bactericidal power of blood against the causal organism. J Immunol 1933 ; 24 : 273-84
4. Makela PH, Peltola H, Kayhty H : Polysaccharide vaccines of group A Neisseria meningitidis and H. influenzae type b : A field trial in Finland. J Infect Dis 1977 ; 136 : S43-50
5. Ward JI, Broome CV, Harrison LH, Shinefield H, Black SB : Haemophilus influenzae type b vaccines : Lessons for the future. Pediatrics 1988 ; 81 : 886-93
6. Centers for Disease Control and Prevention : Progress Towards Eliminating Haemophilus influenzae Type b Disease Among Infants and Children - United States 1998-2000. MMWR 2002 ; 51 : 234-7
7. Peltola H, Kilpi T, Anttila M : Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet 1992 ; 340 : 592-4
8. Hargreaves RM, Slack MP, Howard AJ, Anderson E, Ramsay ME : Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 1996 ; 312 : 160-1
9. Levy J, Swennen B, Henrion E, Devaster JM, Bauche P : Impact de la vaccination sur les infections invasives à Haemophilus influenzae type b. Arch Public Health 1997 ; 55 : 331-9
10. Swennen B, Van Damme P, Vellinga A, Coppieters Y, Depoorter AM : Analysis of factors influencing vaccine uptake : perspectives from Belgium. Vaccine 2001 ; 20 : S5-7
11. Ellis R : Development of combination vaccines. Vaccine 1999 ; 17 : 1635-42
12. Kaythy H, Peltola H, Karanko V, Makela PH : The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzas type b. J Infect Dis 1983 ; 147 : 1100
13. Goldblatt D, Miller E, McCloskey N, Cartwright K : Immunological response to conjugate vaccines in infants : follow up study. BMJ 1998 ; 316 : 1570-1
14. Booy R, Heath PT, Slack MPE, Begg N, Moxon ER : Vaccine failures after primary immunisation with Haemophilus influenzae type b conjugate vaccine without booster. Lancet 1997 ; 349 : 1197-202
15. Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegnst CA : Combined vaccination of Haemophilus influenzae type b conjugate and diphteria-tetanus-pertussis containing acellular pertussis. Lancet 1999 ; 354 : 2063-8
16. Hoppenbrouwers K, Kanra G, Roelants M et al : Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. Vaccine 1999 ; 17 : 875-86
17. Granoff DM, Holmes SJ, Osterholm MT et al : Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993 ; 168 : 663-71
18. Heath P, Booy R, Azzopardi HJ et al : Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 2000 ; 284 : 2334-40
19. Ward JI, Lum MK, Margolis HS et al : H. influenzae disease in Alaskan Eskimos : Characteristics of a population with an unusual incidence of invasive disease. Lancet 1981 ; 1 : 1281-5
20. Singleton R, Bulkow LR, Levine OS et al : Experience with the prevention of invasive Haemophilus influenzae type b by vaccination in Alaska : The impact of persistent oropharyngeal carriage. J Pediatr 2000 ; 137 : 313-20
21. Galil K, Singleton R, Levine OS et al : Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis 1999 ; 179 : 101-6
22. Anonymous : Control and prevention of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 1997; 46 : 1-10
23. Miller E, Salisbury D, Ramsay M : Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK : a success story. Vaccine 2002 ; 20 : S58-67
24. Salleras L, Dominguez A, Prats G et al : Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people. J Epidemiol Community Health 2001 ; 55 : 283-7
25. Conference report : Meningococcal disease in Europe : epidemiology, mortality and prevention with conjugate vaccines. Report of an European advisory board meeting Vienna, Austria, 6-8 October 2000. Vaccine 2001 ; 19 : 4347-56
26. Ramsey M, Kaczmarski EB, Rush M et al : Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales. Commun Dis Rep CDR Rev 1997 ; 7 : R49-54
27. MacLennan JM, Shackley F, Heath PT et al : Safety, immunogenicity and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants. A randomized controlled trial. JAMA 2000 ; 283 : 2795-801
28. Richmond P, Borrow R, Goldblatt D et al : Ability of three different meningococcal C conjugate vaccines to induce immunological memory after a single dose in UK toddlers. J Infect Dis 2001 ; 183 : 160-3
29. Borrow R, Goldblatt D, Southern J et al : Influence of prior meningococcal C polysaccharide vaccine on the response and generation of memory following meningococcal C conjugate vaccine in young children. J Infect Dis 2001 ; 184 : 377-80
30. Richmond P, Kaczmarski E, Borrow R et al : Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis 2000 ; 181 : 761-4
31. Booth L, Naracott E, Greenslade J : Meningitis C immunisation is low among young people who are not in education. BMJ 2000 ; 320 : 805
32. Ramsay ME, Andrews N, Kaczmarski E et al : Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 2001 ; 357 : 195-6
33. Hausdorff WP, Bryant J, Kloek C, Paradiso PR et al : The contribution of specific pneumococcal serogroups to different disease manifestations : implication for conjugate formulation and use. Clin Infect Dis 2000 ; 30 : 122-40
34. Giebink GS : The prevention of pneumococcal disease in children. N Engl J Med 2001 ; 345 : 1177-83
35. Black S, Shinefield H, Fireman B et al : Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000 ; 19 : 187-95
36. Eskola J, Kilpi T, Palmu A et al : Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001 ; 344 : 403-9
37. Black S, Shinefield H, Hansen J, Elvin L, Laufer D, Malinoski F : Postlicencure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001 ; 20 : 1105-7
38. Dagan R, Sikuler-Cohen M, Zamir O et al : Effect of conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotics use in day-care center attendees. Pediatr Infect Dis J 2001 ; 20 : 951-8
39. Dagan R, Fraser D : Conjugate pneumococcal vaccine and antibiotic resistant Streptococcus pneumoniae : herd immunity and reduction of otitis morbidity. Pediatr Infect Dis J 2000 ; 19 : S79-88
40. Spoulou V, Gilks C, Ioannidis J : Protein conjugate pneumococcal vaccines. BMJ 2002 ; 324 : 750-1
41. Anonymus : From the Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage - Advisory Committee on Immunization Practices. JAMA 2002 ; 287 : 833-4